S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
MarketBeat Week in Review – 5/22 - 5/26
3 Free Stock Picks per Day (Ad)
As Elizabeth Holmes heads to prison for fraud, many puzzle over her motives
New bill to build Athletics stadium on Las Vegas Strip caps Nevada's cost at $380 million
3 Free Stock Picks per Day (Ad)
Mechanical sails? Batteries? Shippers forming 'green corridors' to fast-track cleaner technologies
Baby eels remain one of America's most valuable fish after strong year in Maine
Sell every Stock except ONE (Ad)
Teen workers are in high demand for summer and commanding better pay
Biden, GOP reach tentative deal to raise debt ceiling, avoid calamitous US default
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
MarketBeat Week in Review – 5/22 - 5/26
3 Free Stock Picks per Day (Ad)
As Elizabeth Holmes heads to prison for fraud, many puzzle over her motives
New bill to build Athletics stadium on Las Vegas Strip caps Nevada's cost at $380 million
3 Free Stock Picks per Day (Ad)
Mechanical sails? Batteries? Shippers forming 'green corridors' to fast-track cleaner technologies
Baby eels remain one of America's most valuable fish after strong year in Maine
Sell every Stock except ONE (Ad)
Teen workers are in high demand for summer and commanding better pay
Biden, GOP reach tentative deal to raise debt ceiling, avoid calamitous US default
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
MarketBeat Week in Review – 5/22 - 5/26
3 Free Stock Picks per Day (Ad)
As Elizabeth Holmes heads to prison for fraud, many puzzle over her motives
New bill to build Athletics stadium on Las Vegas Strip caps Nevada's cost at $380 million
3 Free Stock Picks per Day (Ad)
Mechanical sails? Batteries? Shippers forming 'green corridors' to fast-track cleaner technologies
Baby eels remain one of America's most valuable fish after strong year in Maine
Sell every Stock except ONE (Ad)
Teen workers are in high demand for summer and commanding better pay
Biden, GOP reach tentative deal to raise debt ceiling, avoid calamitous US default
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
MarketBeat Week in Review – 5/22 - 5/26
3 Free Stock Picks per Day (Ad)
As Elizabeth Holmes heads to prison for fraud, many puzzle over her motives
New bill to build Athletics stadium on Las Vegas Strip caps Nevada's cost at $380 million
3 Free Stock Picks per Day (Ad)
Mechanical sails? Batteries? Shippers forming 'green corridors' to fast-track cleaner technologies
Baby eels remain one of America's most valuable fish after strong year in Maine
Sell every Stock except ONE (Ad)
Teen workers are in high demand for summer and commanding better pay
Biden, GOP reach tentative deal to raise debt ceiling, avoid calamitous US default
NASDAQ:CYRX

Cryoport (CYRX) Stock Forecast, Price & News

$18.67
-0.40 (-2.10%)
(As of 05/26/2023 ET)
Compare
Today's Range
$18.54
$19.41
50-Day Range
$18.67
$24.00
52-Week Range
$15.63
$45.36
Volume
259,992 shs
Average Volume
356,003 shs
Market Capitalization
$850.23 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$29.50

Cryoport MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
58.0% Upside
$29.50 Price Target
Short Interest
Bearish
8.22% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.33mentions of Cryoport in the last 14 days
Based on 5 Articles This Week
Insider Trading
Selling Shares
$3.88 M Sold Last Quarter
Proj. Earnings Growth
Growing
From ($0.64) to ($0.42) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.07 out of 5 stars

Transportation Sector

80th out of 124 stocks

Pharmaceutical Preparations Industry

269th out of 498 stocks


CYRX stock logo

About Cryoport (NASDAQ:CYRX) Stock

CryoPort, Inc. engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide, including points-of-care, clinical research organizations central laboratories, biopharmaceuticals, contract manufacturing, health centers, and university researchers. It offers personalized medicine, immunotherapies, cellular therapies, CAR T-cell therapies, stem cell therapies, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, bio-pharmaceuticals, infectious substances, and other commodities that require continuous exposure to certain ranges of precision-controlled temperatures. The company was founded on May 25, 1990 and is headquartered in Brentwood, TN.

Receive CYRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cryoport and its competitors with MarketBeat's FREE daily newsletter.

CYRX Stock News Headlines

Cryoport (NASDAQ:CYRX) Shares Down 7.4%
CryoPort (CYRX) Rose on Revenue Guidance
15 A.I. Trading Opportunities a Day
Using our algorithm, we sift through 15,000 stocks every second. We generate 15 trading opportunities a day.
8-K: Cryoport, Inc.
15 A.I. Trading Opportunities a Day
Using our algorithm, we sift through 15,000 stocks every second. We generate 15 trading opportunities a day.
Cryoport Reports First Quarter 2023 Results
Macroeconomic Headwinds Dragged Cryoport (CYRX) in Q4
Cryoport Reports Fourth Quarter and Full Year 2022 Results
When Will Cryoport, Inc. (NASDAQ:CYRX) Become Profitable?
Madrigal Pharmaceuticals: Upcoming Windfall Profits
See More Headlines
Receive CYRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cryoport and its competitors with MarketBeat's FREE daily newsletter.

CYRX Company Calendar

Last Earnings
5/04/2023
Today
5/27/2023
Next Earnings (Estimated)
8/03/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:CYRX
Employees
1,024
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$29.50
High Stock Price Forecast
$30.00
Low Stock Price Forecast
$28.00
Forecasted Upside/Downside
+58.0%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
4 Analysts

Profitability

Net Income
$-37,330,000.00
Pretax Margin
-10.94%

Debt

Sales & Book Value

Annual Sales
$237.28 million
Book Value
$11.86 per share

Miscellaneous

Free Float
40,763,000
Market Cap
$850.23 million
Optionable
Optionable
Beta
1.32

Key Executives

  • Jerrell W. SheltonJerrell W. Shelton
    Chairman, President & Chief Executive Officer
  • Robert S. StefanovichRobert S. Stefanovich
    Chief Financial Officer, Secretary & Treasurer
  • Mark W. SawickiMark W. Sawicki
    Chief Scientific Officer
  • Thomas J. Heinzen
    Vice President-Corporate Development













CYRX Stock - Frequently Asked Questions

Should I buy or sell Cryoport stock right now?

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Cryoport in the last twelve months. There are currently 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" CYRX shares.
View CYRX analyst ratings
or view top-rated stocks.

What is Cryoport's stock price forecast for 2023?

4 equities research analysts have issued 1 year price objectives for Cryoport's shares. Their CYRX share price forecasts range from $28.00 to $30.00. On average, they expect the company's share price to reach $29.50 in the next twelve months. This suggests a possible upside of 58.0% from the stock's current price.
View analysts price targets for CYRX
or view top-rated stocks among Wall Street analysts.

How have CYRX shares performed in 2023?

Cryoport's stock was trading at $17.35 at the beginning of 2023. Since then, CYRX shares have increased by 7.6% and is now trading at $18.67.
View the best growth stocks for 2023 here
.

When is Cryoport's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, August 3rd 2023.
View our CYRX earnings forecast
.

How were Cryoport's earnings last quarter?

Cryoport, Inc. (NASDAQ:CYRX) issued its quarterly earnings data on Thursday, May, 4th. The consumer goods maker reported ($0.16) earnings per share for the quarter, topping the consensus estimate of ($0.18) by $0.02. The consumer goods maker had revenue of $62.82 million for the quarter, compared to analyst estimates of $62.15 million. Cryoport had a negative net margin of 11.91% and a negative trailing twelve-month return on equity of 4.90%. The business's revenue was up 20.1% compared to the same quarter last year. During the same quarter in the prior year, the firm posted ($0.31) earnings per share.

What ETFs hold Cryoport's stock?

ETFs with the largest weight of Cryoport (NASDAQ:CYRX) stock in their portfolio include Principal Healthcare Innovators ETF (BTEC), Pacer Industrials and Logistics ETF (SHPP),

What guidance has Cryoport issued on next quarter's earnings?

Cryoport issued an update on its FY 2023 earnings guidance on Thursday, May, 4th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $270.00 million-$290.00 million, compared to the consensus revenue estimate of $273.56 million.

What other stocks do shareholders of Cryoport own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cryoport investors own include Gilead Sciences (GILD), Advanced Micro Devices (AMD), Micron Technology (MU), NVIDIA (NVDA), Taiwan Semiconductor Manufacturing (TSM), Amarin (AMRN), QUALCOMM (QCOM), Enterprise Products Partners (EPD), Pfizer (PFE) and Block (SQ).

What is Cryoport's stock symbol?

Cryoport trades on the NASDAQ under the ticker symbol "CYRX."

Who are Cryoport's major shareholders?

Cryoport's stock is owned by many different retail and institutional investors. Top institutional investors include Brown Capital Management LLC (16.44%), BlackRock Inc. (6.96%), Impax Asset Management Group plc (5.54%), Fred Alger Management LLC (5.30%), Macquarie Group Ltd. (3.08%) and Clearbridge Investments LLC (2.76%). Insiders that own company stock include Daniel M Hancock, Daniel M Hancock, Edward J Zecchini, Freeze Parent LP Blackstone, Jerrell Shelton, Mark W Sawicki, Michael R Egeck, Richard J Berman, Robert J Hariri and Robert Stefanovich.
View institutional ownership trends
.

How do I buy shares of Cryoport?

Shares of CYRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cryoport's stock price today?

One share of CYRX stock can currently be purchased for approximately $18.67.

How much money does Cryoport make?

Cryoport (NASDAQ:CYRX) has a market capitalization of $850.23 million and generates $237.28 million in revenue each year. The consumer goods maker earns $-37,330,000.00 in net income (profit) each year or ($0.78) on an earnings per share basis.

How many employees does Cryoport have?

The company employs 1,024 workers across the globe.

How can I contact Cryoport?

Cryoport's mailing address is 112 Westwood Place Suite 350, Brentwood TN, 37027. The official website for the company is www.cryoport.com. The consumer goods maker can be reached via phone at (949) 470-2300, via email at tfromer@kcsa.com, or via fax at 949-470-2306.

This page (NASDAQ:CYRX) was last updated on 5/27/2023 by MarketBeat.com Staff

My Account -